Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 18.14 EUR 1.43% Market Closed
Market Cap: 13.4B EUR

Operating Margin
Roivant Sciences Ltd

-5 659.4%
Current
-2 457%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5 659.4%
=
Operating Profit
-1.2B
/
Revenue
20.3m

Operating Margin Across Competitors

No Stocks Found

Roivant Sciences Ltd
Glance View

Market Cap
12.5B EUR
Industry
Biotechnology

Roivant Sciences Ltd., founded in 2014 by entrepreneur Vivek Ramaswamy, emerged as a novel entity in the pharmaceutical industry by rethinking the drug development process. At the heart of Roivant’s strategy is its unique model of deploying a family of subsidiaries, each focused on developing a specific therapeutic area, referred to as “Vants.” These subsidiaries operate semi-independently, allowing for a nimble and focused approach to drug development while sharing centralized resources like regulatory expertise and funding strategies from Roivant itself. This decentralized yet coordinated structure aims to sidestep the traditional bottlenecks of large pharmaceutical companies, accelerating the time it takes to bring drugs from development to market. Roivant generates revenue by acquiring underdeveloped or previously shelved drug candidates from other pharmaceutical companies, then developing them through their Vants. Once these drugs have proved their potential through clinical trials, Roivant either licenses them out, partners with other companies for further development and commercialization, or sells a stake in the developed drug or entire Vant. This innovative approach allows them not only to mitigate risks associated with drug development but also to tap into a wide range of therapeutic areas, leveraging modern approaches like digital technology to optimize the drug development pipeline. Through this strategy, Roivant aims to capitalize on the inefficiencies in the pharmaceutical industry, delivering valuable medical solutions while generating substantial economic returns.

87S Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-5 659.4%
=
Operating Profit
-1.2B
/
Revenue
20.3m
What is the Operating Margin of Roivant Sciences Ltd?

Based on Roivant Sciences Ltd's most recent financial statements, the company has Operating Margin of -5 659.4%.

Back to Top